argenx SE reported 61.17M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 1.16B Jun/2025
Galapagos EUR 65.9M 228.04M Jun/2025
Genmab DKK 10M 56M Mar/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Qiagen NV USD 216.83M 214.3M Jun/2025
UCB EUR 584M 0 Dec/2024